News

Stargardt Disease

by Dan Roberts (Updated May 25, 2011) Stargardt disease (also known as fundus flavimaculatus and Stargardt macular dystrophy) is the most common form of inherited juvenile macular degeneration. Inherited as an autosomal recessive trait, it is a severe form of MD that begins in late childhood, leading to legal blindness. Stargardt disease is symptomatically similar [Read More]

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

The CATT Research Group April 2011 In 2005, clinical trials established the efficacy of ranibizumab (Lucentis, Genentech) for the treatment of neovascular age-related macular degeneration (AMD), the leading cause of legal blindness in the United States. While awaiting approval for ranibizumab from the Food and Drug Administration, ophthalmologists began treating neovascular AMD with off-label use [Read More]

Maintaining Independence and Quality of Life

by Dan Roberts March 2011 The “English Longitudinal Study of Ageing” has found that people with poor eyesight are three to five times more likely than those with good eyesight to suffer from low quality of life, poor psychological health, and depression.1 When those inequalities are accounted for, however, the impact of poor eyesight itself [Read More]

“Crossing The Line From Visual To Nonvisual Skills”

An Interview with Maurice Peret (Blind Industries and Services of Maryland) Dan Roberts, Moderator International Low Vision Support Group February 10, 2011 Dan: Welcome to our webcast, Maurice. Please tell us how you became blind and how that led you into your work as rehabilitation trainer for Blind Industries and Services of Maryland. Maurice: How [Read More]